查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612028

美容注射市場：按產品、性別、應用和最終用戶分類 - 全球預測 2025-2030

Aesthetic Injectables Market by Product (Anti-aging Injections, Dermal Fillers), Gender (Female, Male), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年注射美容市場價值為110.8億美元，預計到2024年將達到119.5億美元，複合年成長率為7.85%，到2030年將達到188.1億美元。

美容注射包括真皮填充劑和肉毒毒素，旨在恢復年輕外觀並增強臉部特徵。這些產品解決了各種美容問題，包括減少皺紋、豐唇和臉部輪廓。由於產品配方的進步和不斷成長的老齡化人口尋求美學改善的推動，對非手術、微創美容療程的需求日益成長，這強調了美容注射的需求。使用時，可塗抹於額頭、魚尾紋、臉頰、嘴唇和下巴等臉部區域。主要的最終使用者是美容診所、皮膚科中心、醫院，有時還有牙科診所。市場促進因素包括可支配收入的增加、社交媒體影響下美容趨勢的放大以及美容護理意識的提高。此外，男性消費者的興趣不斷增加，市場進一步擴大。然而，其局限性包括潛在的副作用、某些地區缺乏訓練有素的專業人員以及治療費用高昂。此外，嚴格的法律規範為市場成長帶來了重大挑戰，特別是在產品核可和安全合規方面。為了利用潛在的機會，公司應該專注於擴大產品適應症以涵蓋治療應用，以及創新產品配方以確保提高耐用性和增強可模仿特性。探索生物分解性的替代品和個人化注射劑可能會開創針對性美容療程的新時代。此外，擴大我們在化妝品支出不斷增加的新興市場的地域影響力可以開闢新的業務途徑。在技​​術創新方面，人工智慧諮詢將為每位患者制定個人化的治療計劃，從而有可能提高患者滿意度。市場動態是動態的，主要由消費者情緒和新的美容標準驅動，需要不斷適應和創新以保持競爭優勢。公司需要跟上技術進步和監管變化，以有效利用市場機會。

主要市場統計
基準年[2023] 110.8億美元
預計年份 [2024] 119.5億美元
預測年份 [2030] 188.1億美元
複合年成長率（%） 7.85%

市場動態：揭示快速發展的美容注射市場的關鍵市場洞察

供需的動態交互作用正在改變美容注射市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於美容趨勢和人口老化，美容注射的使用增加
    • 水療中心和美容院的增加
    • 政府和衛生當局改革以推廣美容療程選擇
  • 市場限制因素
    • 美容注射和產品召回的高成本
  • 市場機會
    • 美容注射工具和方法的持續創新
    • 創業投資對美容注射新興企業的投資
  • 市場挑戰
    • 與美容注射相關的健康風險

波特五力：駕馭美容注射市場的策略工具

波特的五力框架是了解美容注射市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對美容注射市場的影響

外部宏觀環境因素對美容注射市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解美容注射市場競爭狀況

美容注射市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位基質化妝品注射劑市場供應商的績效評估

FPNV定位矩陣是評估注射美容市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製美容注射市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，美容注射市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於美容趨勢和人口老化，美容注射的使用正在增加。
      • 水療中心和美容院的增加
      • 政府和衛生當局改革以推廣美容療程選擇
    • 抑制因素
      • 美容注射和產品召回的高成本
    • 機會
      • 美容注射工具和方法的不斷創新
      • 創業投資對美容注射新興企業的投資
    • 任務
      • 與美容注射相關的健康風險
  • 市場區隔分析
    • 類型：增加使用抗衰老注射來減少皺紋
    • 最終使用者：皮膚科診所提供各種美容治療，因此美容注射很容易取得。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章美容注射市場：依產品

  • 抗衰老注射
    • A型肉毒桿菌毒素
    • 聚左旋乳酸（PLLA）微粒
  • 真皮填充劑
    • 膠原蛋白填充劑
    • 玻尿酸
    • 合成填料

第7章美容注射市場性別

  • 女士
  • 男人

第8章美容注射市場：依應用分類

  • 痤瘡疤痕治療
  • 拉皮
  • 臉部線條矯正
  • 豐唇術
  • 脂肪萎縮的治療

第9章美容注射市場：依最終用戶分類

  • 美容診所
  • 皮膚科診所
  • 皮膚科研究所
  • 醫療水療

第10章 北美、南美注射美容市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太美容注射市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲美容注射市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Cynosure與Lutronic合併，成為全球醫學美容技術領導者
    • Galderma推出新的AR工具「FACE by Galderma」以視覺化注射治療結果
    • FDA核准美國新型玻尿酸注射「SKINVIVE by JUVEDERM」 平滑臉頰
  • 戰略分析和建議

公司名單

  • Adoderm GmbH
  • Allergan, Inc. by AbbVie Inc.
  • Anika Therapeutics, Inc.
  • Bio Plus Co., Ltd.
  • Bioxis Pharmaceuticals
  • Bloomage Biotechnology Corp., Ltd.
  • Bohus Biotech AB
  • Croma-Pharma GmbH
  • Cutera, Inc.
  • Cynosure, LLC
  • Dr. Korman Laboratories Ltd.
  • Galderma SA
  • Hugel America, Inc.
  • Ipsen Pharma
  • Laboratoires Vivacy, SAS
  • MedyTox Inc.
  • Merz Pharma GmbH & Co.KGaA
  • Prollenium Medical Technologies Inc.
  • Revance Therapeutics, Inc.
  • SciVision Biotech Inc.
  • Sinclair Pharma Ltd
  • Suneva Medical, Inc.
  • Teoxane SA
  • USWM, LLC
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-6702BB6513EA

The Aesthetic Injectables Market was valued at USD 11.08 billion in 2023, expected to reach USD 11.95 billion in 2024, and is projected to grow at a CAGR of 7.85%, to USD 18.81 billion by 2030.

Aesthetic injectables, encompassing dermal fillers and botulinum toxins, aim to restore a youthful appearance and enhance facial features. These products address various aesthetic concerns, including wrinkle reduction, lip augmentation, and facial contouring. The growing desire for non-surgical and minimally invasive cosmetic treatments, fueled by advancements in product formulations and an increasing aging population seeking aesthetic improvements, underscores the necessity for aesthetic injectables. Application-wise, these can be administered to facial areas like the forehead, crow's feet, cheeks, lips, and jawline. The primary end-users include cosmetic clinics, dermatology centers, hospitals, and at times, dental practices. Market insights reveal key growth drivers such as rising disposable incomes, social media influence amplifying beauty trends, and heightened awareness of aesthetic treatment availability. Additionally, male consumer interest is growing, further expanding the market. However, limitations include potential side effects, a lack of trained professionals in certain regions, and the premium cost of treatments. Moreover, stringent regulatory frameworks pose significant challenges to market growth, especially regarding product approval and safety compliance. To leverage potential opportunities, companies should focus on innovation in product formulations ensuring enhanced durability and mimetic enhancement, alongside expanding product indications to encompass therapeutic uses. Research into biodegradable alternatives and personalized injectables could usher in a new era of targeted cosmetic therapies. Additionally, expanding geographic presence in emerging markets with increasing cosmetic spending could provide new business avenues. On the innovation front, AI-driven consultations can allow for personalized treatment plans, improving patient satisfaction. The aesthetic injectables market is dynamic and primarily driven by consumer sentiments and emerging beauty standards, necessitating continuous adaptation and innovation to maintain competitive advantage. Businesses should stay abreast of technological advances and regulatory changes to effectively capitalize on market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 11.08 billion
Estimated Year [2024] USD 11.95 billion
Forecast Year [2030] USD 18.81 billion
CAGR (%) 7.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aesthetic Injectables Market

The Aesthetic Injectables Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising usage of aesthetic injections due to beauty trends and aging population
    • Increasing number of spa and beauty salons
    • Government and health authority reforms that promote aesthetic treatment options
  • Market Restraints
    • High cost of aesthetic injectables and product recalls
  • Market Opportunities
    • Ongoing innovations in the tools and methods used for administering aesthetic injectables
    • Venture capital investments into aesthetic injectable start-ups
  • Market Challenges
    • Health risks associated with aesthetic injectables

Porter's Five Forces: A Strategic Tool for Navigating the Aesthetic Injectables Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aesthetic Injectables Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aesthetic Injectables Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aesthetic Injectables Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aesthetic Injectables Market

A detailed market share analysis in the Aesthetic Injectables Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aesthetic Injectables Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aesthetic Injectables Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aesthetic Injectables Market

A strategic analysis of the Aesthetic Injectables Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aesthetic Injectables Market, highlighting leading vendors and their innovative profiles. These include Adoderm GmbH, Allergan, Inc. by AbbVie Inc., Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp., Ltd., Bohus Biotech AB, Croma-Pharma GmbH, Cutera, Inc., Cynosure, LLC, Dr. Korman Laboratories Ltd., Galderma SA, Hugel America, Inc., Ipsen Pharma, Laboratoires Vivacy, S.A.S., MedyTox Inc., Merz Pharma GmbH & Co.KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., SciVision Biotech Inc., Sinclair Pharma Ltd, Suneva Medical, Inc., Teoxane SA, USWM, LLC, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Aesthetic Injectables Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Anti-aging Injections and Dermal Fillers. The Anti-aging Injections is further studied across Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Micro Particles. The Dermal Fillers is further studied across Collagen Fillers, Hyaluronic Acid, and Synthetic Fillers.
  • Based on Gender, market is studied across Female and Male.
  • Based on Application, market is studied across Acne Scar Treatment, Face Lift, Facial Line Correction, Lip Augmentation, and Lipoatrophy Treatment.
  • Based on End User, market is studied across Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes, and Medical Spa.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising usage of aesthetic injections due to beauty trends and aging population
      • 5.1.1.2. Increasing number of spa and beauty salons
      • 5.1.1.3. Government and health authority reforms that promote aesthetic treatment options
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of aesthetic injectables and product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations in the tools and methods used for administering aesthetic injectables
      • 5.1.3.2. Venture capital investments into aesthetic injectable start-ups
    • 5.1.4. Challenges
      • 5.1.4.1. Health risks associated with aesthetic injectables
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of anti-aging injections to reduce the appearance of wrinkles
    • 5.2.2. End User: High accessibility of aesthetic injectables by dermatology clinics as they provide several cosmetic treatments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Aesthetic Injectables Market, by Product

  • 6.1. Introduction
  • 6.2. Anti-aging Injections
    • 6.2.1. Botulinum Toxin A
    • 6.2.2. Poly-L-Lactic Acid (PLLA) Micro Particles
  • 6.3. Dermal Fillers
    • 6.3.1. Collagen Fillers
    • 6.3.2. Hyaluronic Acid
    • 6.3.3. Synthetic Fillers

7. Aesthetic Injectables Market, by Gender

  • 7.1. Introduction
  • 7.2. Female
  • 7.3. Male

8. Aesthetic Injectables Market, by Application

  • 8.1. Introduction
  • 8.2. Acne Scar Treatment
  • 8.3. Face Lift
  • 8.4. Facial Line Correction
  • 8.5. Lip Augmentation
  • 8.6. Lipoatrophy Treatment

9. Aesthetic Injectables Market, by End User

  • 9.1. Introduction
  • 9.2. Beauty Clinics
  • 9.3. Dermatology Clinics
  • 9.4. Dermatology Research Institutes
  • 9.5. Medical Spa

10. Americas Aesthetic Injectables Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Aesthetic Injectables Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Aesthetic Injectables Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Cynosure and Lutronic Merge to Form Global Leader in Medical Aesthetic Technology
    • 13.3.2. Galderma Launches FACE by Galderma, a New AR Tool Helps Visualize Injectable Treatment Results
    • 13.3.3. FDA Approves SKINVIVE by JUVEDERM, a new U.S. Hyaluronic Acid Injection for Smoother Cheeks
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adoderm GmbH
  • 2. Allergan, Inc. by AbbVie Inc.
  • 3. Anika Therapeutics, Inc.
  • 4. Bio Plus Co., Ltd.
  • 5. Bioxis Pharmaceuticals
  • 6. Bloomage Biotechnology Corp., Ltd.
  • 7. Bohus Biotech AB
  • 8. Croma-Pharma GmbH
  • 9. Cutera, Inc.
  • 10. Cynosure, LLC
  • 11. Dr. Korman Laboratories Ltd.
  • 12. Galderma SA
  • 13. Hugel America, Inc.
  • 14. Ipsen Pharma
  • 15. Laboratoires Vivacy, S.A.S.
  • 16. MedyTox Inc.
  • 17. Merz Pharma GmbH & Co.KGaA
  • 18. Prollenium Medical Technologies Inc.
  • 19. Revance Therapeutics, Inc.
  • 20. SciVision Biotech Inc.
  • 21. Sinclair Pharma Ltd
  • 22. Suneva Medical, Inc.
  • 23. Teoxane SA
  • 24. USWM, LLC
  • 25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. AESTHETIC INJECTABLES MARKET RESEARCH PROCESS
  • FIGURE 2. AESTHETIC INJECTABLES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AESTHETIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AESTHETIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AESTHETIC INJECTABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AESTHETIC INJECTABLES MARKET DYNAMICS
  • TABLE 7. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY ACNE SCAR TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACE LIFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY LIP AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY LIPOATROPHY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY MEDICAL SPA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. AESTHETIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. AESTHETIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023